International consortium for optical genome mapping publishes expert recommendations for integration of ogm as a standard-of-care cytogenetic assay for diagnostic workflows in blood cancers

San diego, may 02, 2025 (globe newswire) -- bionano laboratories, a wholly-owned subsidiary of bionano genomics, inc. (nasdaq: bngo) that offers clia-certified laboratory developed tests (ldts) based on optical genome mapping (ogm), today announced the publication in the american journal of hematology of expert recommendations from the international consortium for optical genome mapping (icogm) for the integration of ogm as a standard-of-care (soc) cytogenetic assay for diagnostic workflows in various clinical settings. nineteen (19) experts from the icogm, representing relevant multidisciplinary fields, conducted an in-depth review of the classification of hematolymphoid malignancies using the world health organization (who, 5th ed.
BNGO Ratings Summary
BNGO Quant Ranking